RedHill Biopharma Prices Public Offering of Its American Depository Shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
RedHill Biopharma (RDHL) Prices 2.46M Public Offering at $16.25/ADS
July 17, 2015 6:43 AM EDTRedHill Biopharma (Nasdaq: RDHL) announced the pricing of its previously announced underwritten public offering, for a total amount of 2,462,000 American Depository Shares ("ADSs"), each representing ten of its ordinary shares, at an offering price of $16.25 per ADS.
Gross proceeds from the sale of... More
